Personnel Announcement
Novo Nordisk Pharma has announced new personnel appointments effective March 1, 2026. Ryo Kato has been appointed as Head of the Healthcare Policy and External Affairs Division, and Junko McMaster has been appointed as Director of the Corporate Affairs Department.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 19:00
- 🔍 Collected: March 30, 2026 at 22:56 (3h 56m after Published)
- 🤖 AI Analyzed: June 2, 2026 at 13:02 (1526h 6m after Collected)
Novo Nordisk Pharma Ltd. (President: Keisuke Kotani, Headquarters: Chiyoda-ku, Tokyo; hereinafter "Novo Nordisk Pharma") hereby announces the following personnel changes.
① Personnel Changes (Effective March 1, 2026)
Name | New Position | Former Position |
Ryo Kato | Head of Healthcare Policy and External Affairs Division | Head of Public Affairs Department, Healthcare Policy and External Affairs Division |
Name | New Position | Former Position |
Junko McMaster | Director, Corporate Affairs Department | — |
About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, building upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs approximately 68,800 people in 80 countries and markets its products in around 170 countries. Novo Nordisk Pharma Ltd., the Japanese subsidiary, was established in 1980. For more information, visit our website at www.novonordisk.co.jp